Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 8:58 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2065–2088 of 3,580 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: patch Clear all

Conditions: Actinic Keratosis, Squamous Cell Carcinoma
Interventions: Superficial shave biopsy; Procedure
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Adhesive Capsulitis of the Shoulder, Frozen Shoulder
Interventions: Hormone Replacement Therapy (HRT), Corticosteroid and 1%lidocain, physical therapy; Drug · Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 40 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Adenocarcinoma of the Prostate
Interventions: NanoPac®; Drug
Lead sponsor: NanOlogy, LLC; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Stroke With Hemiparesis
Interventions: Alternate Hand Training or Affected Hand Training; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 75 Years
Enrollment: 91 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Skin Sensitisation
Interventions: ColActive Plus Collagen Matrix Dressing; Device
Lead sponsor: Covalon Technologies Inc.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 86 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Torrance, California

Conditions: Decreasing On-Shift Stress With a Crisis Intervention Cart
Interventions: Aromatherapy patches; Combination Product
Lead sponsor: Methodist Health System; Other
Eligibility: 18 Years to 75 Years
Enrollment: 443 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Locally Advanced Cutaneous Squamous Cell Carcinoma
Interventions: L19IL2/L19TNF; Drug
Lead sponsor: Philogen S.p.A.; Industry
Eligibility: 18 Years and older
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 6
States / cities: Orange, California • Atlanta, Georgia • Boston, Massachusetts + 3 more

Conditions: Tumors, Breast
Interventions: digital mammography; Procedure
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 433 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2020
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Multiple Sclerosis, Relapsing-remitting
Interventions: MRI; Device
Lead sponsor: University at Buffalo; Other
Eligibility: 18 Years to 55 Years
Enrollment: 159 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Smoking, Cigarette, Smoking Cessation
Interventions: Varenicline, Combination nicotine patch and nicotine mini-lozenge treatment, Monetary incentives for initiating treatment, Automated tailored outreach, Care management, Wisconsin Tobacco Quit Line referral, Primary care provider referral, Untailored outreach, Multiple smoking cessation coaching calls; Drug · Behavioral · Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: High-Risk Oral Precancerous Disease
Interventions: RP2 Injection; Biological
Lead sponsor: Glenn J. Hanna; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: ECG, Electrocardiography, Monitoring, Physiologic
Interventions: Chest-Worn ECG Monitoring Device; Device
Lead sponsor: Perin Health Devices; Industry
Eligibility: 22 Years to 90 Years
Enrollment: 255 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Woodland Hills, California

Conditions: Spondylolisthesis, Lumbosacral Region
Interventions: Mokhuri intensive treatment, Non-surgical conventional standard treatment; Other
Lead sponsor: Kim Ki Ok; Other
Eligibility: 19 Years to 78 Years
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Smoking
Interventions: Varenicline, Nicotine Transdermal Patch, Nicotine Mini; Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 99 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Chalazion
Interventions: 5-fluorouracil Injection, Triamcinolone Acetonide, Incision and Curettage, Triamcinolone Acetonide/5-fluorouracil mixture; Drug · Procedure
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Discoid Lupus Erythematosus
Interventions: Ruxolitinib; Drug
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Cervical Squamous Cell Carcinoma In Situ, Vulvar High Grade Squamous Intraepithelial Lesion
Interventions: Cyclophosphamide, Indomethacin, IRX-2, Laboratory Biomarker Analysis, Multivitamin, Omeprazole, Placebo, Therapeutic Conventional Surgery; Drug · Biological · Other + 2 more
Lead sponsor: University of Southern California; Other
Eligibility: 25 Years and older · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 2
States / cities: Los Angeles, California • Oklahoma City, Oklahoma

Conditions: Dental Caries
Interventions: A "simple medical strategy" consisting of silver diamine fluoride (SDF), A "typical dental strategy" consisting of atraumatic restorative treatment (ART) with glass ionomer cement + Fluoride Varnish (FV); Device
Lead sponsor: Case Western Reserve University; Other
Eligibility: 62 Years and older
Enrollment: 480 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Squamous Cell Carcinoma of Head and Neck, Locally Advanced Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Interventions: RP3, CCRT(concurrent chemoradiation therapy), carboplatin and paclitaxel, nivolumab; Biological · Other
Lead sponsor: Replimune, Inc.; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 12
States / cities: La Jolla, California • Los Angeles, California • Iowa City, Iowa + 8 more

Conditions: Arterial Occlusion, Angina Pectoris, Cardiovascular Diseases, Atherosclerosis, Hematoma, Anticoagulant-Induced Bleeding, Coronary Artery Disease
Interventions: StatSeal, TR Band; Device
Lead sponsor: VA Long Beach Healthcare System; Federal
Eligibility: 18 Years and older
Enrollment: 184 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Long Beach, California

Conditions: Allergic Contact Dermatitis
Interventions: AI-based smartphone application, Allergen patch; Device · Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 233 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Measurement of Circulation on Anatomical Locations of the Body
Interventions: Sustained Acoustic Medicine, 2.5% Diclofenac Patches; Device · Drug
Lead sponsor: ZetrOZ, Inc.; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 67 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Trumbull, Connecticut

Conditions: Vulvar Cancer
Interventions: imiquimod, biopsy, therapeutic conventional surgery; Drug · Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2018
U.S. locations: 2
States / cities: New York, New York • Columbus, Ohio

Conditions: Corneal Toxicity, Ototoxicity, Surgical Site Infection
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Rochester, Minnesota

Search by objective public record fields.

Nanocytology Test to Evaluate Skin Cancer in High Risk Patients

Frozen Shoulder and Hormone Replacement Therapy

Trial of NanoPac® Focal Therapy in Subjects With Prostate Cancer

Strategies for Recovery of Dexterity Post Stroke

HRIPT for Collagen Dressing

Decreasing On-Shift Stress With a Crisis Intervention Cart

L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma

Digital Mammography: Computer-Aided Breast Cancer Diagnosis

Assessment of Lesion Activity Analysis in the Avonex- Steroid Azathioprine (ASA) Study

Health Systems Reach Interventions Project

Phase II Study of RP2 as Immunoprevention in High-Risk Oral Precancerous Disease

Validation of Perin Health Patch ECG Monitoring Device Performance and Placement Accuracy

Korean Medicine for Symptomatic Lumbar Spinal Spondylolisthesis

UW-CTRI Triple Medication Smoking Cessation Study

Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

Study of Ruxolitinib Cream for the Treatment of Discoid Lupus Erythematosus

IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3

LT Comparative Effectiveness of 2 Caries Treatments

Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHN

Comparing TR Band to Statseal in Conjunction With TR Band

Allergy Skin Patch Artificial Intelligence (AI)

Comparative Evaluation of Sustained Acoustic Medicine Device on Circulation

Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva

A Comparison of Infection Rates Between Two Surgical Sites